Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/12065

TDMS Study 05203-08 Pathology Tables

NTP Experiment-Test: 05203-08         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           O-NITROTOLUENE                                      Date: 11/16/00
Route: DOSED FEED                                                                                                 Time: 09:23:03

                                                   RATS, FINAL#1; CORE STUDY




       Facility:  Southern Research Institute

       Chemical CAS #:  88-72-2

       Lock Date:  12/10/98

       Cage Range:  All

       Reasons For Removal:    25022 Accidently Killed                 25019 Moribund Sacrifice
                               25020 Natural Death                     25021 Terminal Sacrifice

       Removal Date Range:     All

       Treatment Groups:       Include 002    0 PPM
                               Include 004    625 PPM
                               Include 006    1250 PPM
                               Include 008    2000 PPM
                               Include 001    0 PPM
                               Include 003    625 PPM
                               Include 005    1250 PPM
                               Include 007    2000 PPM


























a  Number of animals examined microscopically at site and number of animals with lesion

                                                              Page   1


NTP Experiment-Test: 05203-08         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                           O-NITROTOLUENE                                      Date: 11/16/00    
Route: DOSED FEED                                                                                                 Time: 09:23:03    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS FEMALE                   0 PPM        625 PPM      1250 PPM     2000 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
DISPOSITION SUMMARY                                                                                                                 
                                                                                                                                    
  Animals Initially In Study                          60           60           60           60                                     
  Early Deaths                                                                                                                      
    Moribund Sacrifice                                10           11           19           22                                     
    Natural Death                                      3            2            2            5                                     
  Survivors                                                                                                                         
    Terminal Sacrifice                                45           46           39           33                                     
    Moribund Sacrifice                                 1            1                                                               
    Natural Death                                      1                                                                            
                                                                                                                                    
  Animals Examined Microscopically                    60           60           60           60                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Intestine Large, Colon                             (58)         (59)         (60)         (59)                                   
      Crypt, Diverticulum                              1 (2%)                                                                       
   Intestine Large, Rectum                            (60)         (60)         (60)         (58)                                   
      Fibrosis                                                                   1 (2%)                                             
   Intestine Large, Cecum                             (58)         (59)         (60)         (59)                                   
      Edema                                                         1 (2%)       1 (2%)                                             
   Liver                                              (60)         (59)         (60)         (60)                                   
      Angiectasis                                      2 (3%)       3 (5%)       4 (7%)       4 (7%)                                
      Basophilic Focus                                51 (85%)     56 (95%)     60 (100%)    54 (90%)                               
      Clear Cell Focus                                16 (27%)     30 (51%)     28 (47%)     33 (55%)                               
      Degeneration, Cystic                                                       1 (2%)       2 (3%)                                
      Eosinophilic Focus                               5 (8%)      12 (20%)     25 (42%)     32 (53%)                               
      Hematopoietic Cell Proliferation                              2 (3%)       1 (2%)       3 (5%)                                
      Hemorrhage                                                    1 (2%)       1 (2%)                                             
      Hepatodiaphragmatic Nodule                       9 (15%)     13 (22%)     10 (17%)      7 (12%)                               
      Infiltration Cellular, Mixed Cell               15 (25%)     11 (19%)      6 (10%)     12 (20%)                               
      Mixed Cell Focus                                 6 (10%)      9 (15%)     11 (18%)     28 (47%)                               
      Necrosis, Focal                                               1 (2%)       3 (5%)       5 (8%)                                
      Regeneration, Diffuse                                                                   1 (2%)                                
      Regeneration, Focal                              1 (2%)       2 (3%)                                                          
      Bile Duct, Hyperplasia                           7 (12%)      2 (3%)                                                          
      Centrilobular, Necrosis                          3 (5%)                    2 (3%)       2 (3%)                                
      Hepatocyte, Vacuolization Cytoplasmic            4 (7%)       2 (3%)       1 (2%)                                             
      Kupffer Cell, Pigmentation                       3 (5%)                                                                       
   Mesentery                                          (9)          (1)          (3)          (3)                                    
      Accessory Spleen                                 2 (22%)                   1 (33%)      1 (33%)                               
      Fat, Necrosis                                    7 (78%)      1 (100%)     2 (67%)                                            
   Pancreas                                           (60)         (59)         (60)         (60)                                   
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    2                                                              
                                                                                                                                   
NTP Experiment-Test: 05203-08         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                           O-NITROTOLUENE                                      Date: 11/16/00    
Route: DOSED FEED                                                                                                 Time: 09:23:03    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS FEMALE                   0 PPM        625 PPM      1250 PPM     2000 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Atrophy                                         13 (22%)     10 (17%)      7 (12%)      4 (7%)                                
      Acinus, Hyperplasia, Focal                       1 (2%)       1 (2%)       2 (3%)       2 (3%)                                
   Salivary Glands                                    (60)         (60)         (60)         (60)                                   
      Atrophy                                          2 (3%)       3 (5%)       9 (15%)     48 (80%)                               
   Stomach, Forestomach                               (59)         (59)         (60)         (60)                                   
      Erosion                                          1 (2%)                    1 (2%)                                             
      Perforation                                                   1 (2%)                                                          
      Ulcer                                            1 (2%)       1 (2%)                    1 (2%)                                
      Epithelium, Hyperplasia                          5 (8%)       3 (5%)       1 (2%)                                             
   Stomach, Glandular                                 (60)         (59)         (60)         (60)                                   
      Erosion                                          1 (2%)       1 (2%)       1 (2%)       3 (5%)                                
      Ulcer                                            2 (3%)                    1 (2%)       1 (2%)                                
   Tooth                                              (2)                                                                           
      Inflammation, Chronic                            1 (50%)                                                                      
      Malformation                                     2 (100%)                                                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (60)         (60)         (60)         (60)                                   
      Cardiomyopathy                                  22 (37%)     16 (27%)     13 (22%)     13 (22%)                               
      Thrombosis                                                                 1 (2%)                                             
      Myocardium, Fibrosis                             1 (2%)       1 (2%)                    1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (60)         (60)         (60)         (59)                                   
      Accessory Adrenal Cortical Nodule                8 (13%)     10 (17%)      8 (13%)     10 (17%)                               
      Degeneration, Fatty                             13 (22%)     11 (18%)     17 (28%)     11 (19%)                               
      Hyperplasia, Diffuse                             3 (5%)       1 (2%)                    1 (2%)                                
      Hyperplasia, Focal                               9 (15%)      6 (10%)     14 (23%)     15 (25%)                               
      Hypertrophy, Focal                               6 (10%)      7 (12%)      6 (10%)      7 (12%)                               
      Necrosis                                         1 (2%)                                                                       
   Adrenal Medulla                                    (60)         (60)         (60)         (58)                                   
      Hyperplasia                                      8 (13%)      2 (3%)       3 (5%)       3 (5%)                                
   Pituitary Gland                                    (59)         (60)         (60)         (60)                                   
      Pars Distalis, Angiectasis                       6 (10%)      5 (8%)       4 (7%)       4 (7%)                                
      Pars Distalis, Cyst                             22 (37%)     20 (33%)     22 (37%)     24 (40%)                               
      Pars Distalis, Hyperplasia, Focal               12 (20%)      6 (10%)     12 (20%)      9 (15%)                               
      Pars Intermedia, Angiectasis                                  2 (3%)       1 (2%)                                             
      Pars Intermedia, Cyst                            3 (5%)       1 (2%)       1 (2%)       1 (2%)                                
   Thyroid Gland                                      (60)         (60)         (60)         (60)                                   
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    3                                                              
                                                                                                                                   
NTP Experiment-Test: 05203-08         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                           O-NITROTOLUENE                                      Date: 11/16/00    
Route: DOSED FEED                                                                                                 Time: 09:23:03    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS FEMALE                   0 PPM        625 PPM      1250 PPM     2000 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ENDOCRINE SYSTEM - CONT                                                                                                             
      Ultimobranchial Cyst                             1 (2%)       1 (2%)       1 (2%)                                             
      C-Cell, Hyperplasia                             22 (37%)     24 (40%)     22 (37%)      9 (15%)                               
      Follicle, Cyst                                                2 (3%)       1 (2%)       1 (2%)                                
      Follicular Cell, Hyperplasia                                  1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Clitoral Gland                                     (59)         (57)         (54)         (53)                                   
      Atrophy                                          1 (2%)       3 (5%)       6 (11%)     25 (47%)                               
      Cyst                                             2 (3%)       4 (7%)       4 (7%)       2 (4%)                                
      Hyperplasia                                      5 (8%)       1 (2%)       4 (7%)       1 (2%)                                
      Inflammation, Chronic                            4 (7%)       4 (7%)       6 (11%)      5 (9%)                                
   Ovary                                              (60)         (59)         (60)         (60)                                   
      Angiectasis                                                                             2 (3%)                                
      Cyst                                             9 (15%)      8 (14%)     11 (18%)      6 (10%)                               
   Uterus                                             (60)         (59)         (60)         (60)                                   
      Angiectasis                                      1 (2%)                                                                       
      Cyst                                                                                    1 (2%)                                
      Hydrometra                                       7 (12%)      6 (10%)      1 (2%)       3 (5%)                                
      Hyperplasia, Cystic                              8 (13%)      6 (10%)      9 (15%)      8 (13%)                               
      Inflammation, Chronic                            2 (3%)       1 (2%)       1 (2%)                                             
      Epithelium, Hyperplasia                                                                 1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (60)         (60)         (60)         (60)                                   
      Hyperplasia                                      2 (3%)       7 (12%)     15 (25%)     24 (40%)                               
      Infiltration Cellular, Histiocyte                2 (3%)       1 (2%)       1 (2%)                                             
      Myelofibrosis                                    1 (2%)                                 2 (3%)                                
   Lymph Node                                         (8)          (4)          (4)          (4)                                    
      Mediastinal, Hemorrhage                          1 (13%)      1 (25%)      1 (25%)      3 (75%)                               
      Mediastinal, Pigmentation                        6 (75%)      1 (25%)      1 (25%)      3 (75%)                               
      Renal, Hemorrhage                                                                       1 (25%)                               
      Renal, Pigmentation                                                                     1 (25%)                               
   Lymph Node, Mandibular                             (60)         (60)         (59)         (59)                                   
      Ectasia                                          1 (2%)       3 (5%)                    4 (7%)                                
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    4                                                              
                                                                                                                                   
NTP Experiment-Test: 05203-08         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                           O-NITROTOLUENE                                      Date: 11/16/00    
Route: DOSED FEED                                                                                                 Time: 09:23:03    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS FEMALE                   0 PPM        625 PPM      1250 PPM     2000 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
      Hemorrhage                                       4 (7%)       4 (7%)       1 (2%)       4 (7%)                                
      Hyperplasia, Lymphoid                            3 (5%)       5 (8%)       6 (10%)     15 (25%)                               
      Pigmentation                                    31 (52%)     33 (55%)     30 (51%)     30 (51%)                               
   Lymph Node, Mesenteric                             (59)         (58)         (59)         (59)                                   
      Hemorrhage                                       5 (8%)       3 (5%)       4 (7%)       5 (8%)                                
      Hyperplasia, Lymphoid                                                                   1 (2%)                                
      Pigmentation                                                  4 (7%)       1 (2%)       3 (5%)                                
   Spleen                                             (60)         (59)         (60)         (59)                                   
      Congestion                                                    1 (2%)                                                          
      Fibrosis                                         1 (2%)                    1 (2%)                                             
      Hematopoietic Cell Proliferation                22 (37%)     38 (64%)     48 (80%)     48 (81%)                               
      Necrosis                                         2 (3%)                                                                       
      Pigmentation                                    36 (60%)     44 (75%)     43 (72%)     46 (78%)                               
      Lymphoid Follicle, Atrophy                                    1 (2%)                    1 (2%)                                
   Thymus                                             (57)         (55)         (58)         (58)                                   
      Cyst                                             1 (2%)                    2 (3%)       2 (3%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (60)         (60)         (59)         (60)                                   
      Dilatation                                      40 (67%)     30 (50%)     29 (49%)     24 (40%)                               
      Galactocele                                                   1 (2%)                                                          
      Hyperplasia                                     14 (23%)     36 (60%)     30 (51%)     19 (32%)                               
   Skin                                               (59)         (60)         (60)         (60)                                   
      Angiectasis                                                                1 (2%)                                             
      Ulcer                                            1 (2%)                                                                       
      Subcutaneous Tissue, Edema                                                 1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (60)         (60)         (60)         (60)                                   
      Cranium, Osteopetrosis                           2 (3%)       6 (10%)      6 (10%)     10 (17%)                               
      Femur, Osteopetrosis                             8 (13%)      9 (15%)     13 (22%)     16 (27%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (60)         (60)         (60)         (60)                                   
      Compression                                      6 (10%)     10 (17%)      5 (8%)       3 (5%)                                
      Hydrocephalus                                    2 (3%)       4 (7%)                    3 (5%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    5                                                              
                                                                                                                                   
NTP Experiment-Test: 05203-08         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                           O-NITROTOLUENE                                      Date: 11/16/00    
Route: DOSED FEED                                                                                                 Time: 09:23:03    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS FEMALE                   0 PPM        625 PPM      1250 PPM     2000 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (60)         (60)         (60)         (60)                                   
      Hemorrhage                                       2 (3%)       2 (3%)       2 (3%)       1 (2%)                                
      Infiltration Cellular, Histiocyte               52 (87%)     54 (90%)     53 (88%)     55 (92%)                               
      Alveolar Epithelium, Hyperplasia                 6 (10%)     14 (23%)     16 (27%)      9 (15%)                               
      Alveolar Epithelium, Hyperplasia, Atypical                                              1 (2%)                                
   Nose                                               (60)         (60)         (60)         (60)                                   
      Foreign Body                                     2 (3%)                                 7 (12%)                               
      Inflammation, Chronic                            2 (3%)       1 (2%)       2 (3%)       8 (13%)                               
      Respiratory Epithelium, Hyperplasia              2 (3%)                                 3 (5%)                                
      Respiratory Epithelium, Metaplasia, Squamous                               1 (2%)       1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (3)          (3)          (2)          (1)                                    
      Cataract                                         1 (33%)      2 (67%)      1 (50%)      1 (100%)                              
      Hemorrhage                                       1 (33%)                                                                      
      Inflammation, Chronic                            1 (33%)      1 (33%)                                                         
      Retina, Degeneration                             2 (67%)      2 (67%)      1 (50%)      1 (100%)                              
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (60)         (59)         (60)         (60)                                   
      Cyst                                                          1 (2%)       1 (2%)                                             
      Hydronephrosis                                                             1 (2%)                                             
      Infarct                                          2 (3%)                    1 (2%)                                             
      Inflammation, Chronic                            2 (3%)       1 (2%)       1 (2%)       1 (2%)                                
      Nephropathy                                     53 (88%)     45 (76%)     48 (80%)     52 (87%)                               
      Renal Tubule, Cytoplasmic Alteration                          1 (2%)       1 (2%)                                             
      Renal Tubule, Degeneration, Hyaline              9 (15%)     10 (17%)      4 (7%)      11 (18%)                               
      Renal Tubule, Necrosis                           2 (3%)                                                                       
      Renal Tubule, Pigmentation                       9 (15%)     10 (17%)      7 (12%)     17 (28%)                               
      Transitional Epithelium, Hyperplasia             1 (2%)                    1 (2%)       1 (2%)                                
   Urinary Bladder                                    (60)         (59)         (60)         (60)                                   
      Transitional Epithelium, Hyperplasia                                       1 (2%)                                             
                                                                                                                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                             Page    6                                                              
                                                                                                                                   
NTP Experiment-Test: 05203-08         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                           O-NITROTOLUENE                                      Date: 11/16/00    
Route: DOSED FEED                                                                                                 Time: 09:23:03    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS MALE                     0 PPM        625 PPM      1250 PPM     2000 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
DISPOSITION SUMMARY                                                                                                                 
                                                                                                                                    
  Animals Initially In Study                          70           60           60           60                                     
  Early Deaths                                                                                                                      
    Moribund Sacrifice                                18           35           48           53                                     
    Natural Death                                      3            7            6            7                                     
    Accidently Killed                                                            3                                                  
  Survivors                                                                                                                         
    Terminal Sacrifice                                38           18            3                                                  
    Natural Death                                      1                                                                            
                                                                                                                                    
  Animals Examined Microscopically                    60           60           60           60                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Intestine Large, Cecum                             (60)         (60)         (60)         (58)                                   
      Edema                                            1 (2%)                                                                       
   Liver                                              (60)         (60)         (60)         (60)                                   
      Angiectasis                                                   1 (2%)       2 (3%)       2 (3%)                                
      Atrophy                                          1 (2%)       1 (2%)       1 (2%)       4 (7%)                                
      Basophilic Focus                                38 (63%)     22 (37%)     21 (35%)     25 (42%)                               
      Clear Cell Focus                                29 (48%)     29 (48%)     34 (57%)     31 (52%)                               
      Cyst                                                                                    1 (2%)                                
      Degeneration, Cystic                             3 (5%)       3 (5%)       1 (2%)       2 (3%)                                
      Eosinophilic Focus                               7 (12%)     18 (30%)     29 (48%)     24 (40%)                               
      Fibrosis                                                      1 (2%)                                                          
      Hematopoietic Cell Proliferation                              6 (10%)      2 (3%)       2 (3%)                                
      Hemorrhage                                       2 (3%)                    2 (3%)       2 (3%)                                
      Hepatodiaphragmatic Nodule                       5 (8%)       8 (13%)      8 (13%)      5 (8%)                                
      Infiltration Cellular, Mixed Cell                1 (2%)       5 (8%)      11 (18%)     20 (33%)                               
      Mixed Cell Focus                                 5 (8%)       7 (12%)     12 (20%)      6 (10%)                               
      Necrosis, Focal                                  3 (5%)       4 (7%)       6 (10%)      6 (10%)                               
      Bile Duct, Hyperplasia                          53 (88%)     37 (62%)      7 (12%)                                            
      Centrilobular, Necrosis                          1 (2%)       3 (5%)       8 (13%)      5 (8%)                                
      Hepatocyte, Vacuolization Cytoplasmic            4 (7%)       2 (3%)       1 (2%)       1 (2%)                                
      Kupffer Cell, Pigmentation                       4 (7%)                    1 (2%)       3 (5%)                                
   Mesentery                                          (16)         (6)          (5)          (4)                                    
      Accessory Spleen                                 3 (19%)                                3 (75%)                               
      Congestion                                       3 (19%)                                                                      
      Hemorrhage                                                    1 (17%)                                                         
      Fat, Necrosis                                   13 (81%)      3 (50%)      5 (100%)     1 (25%)                               
   Oral Mucosa                                                                  (1)          (1)                                    
      Hyperplasia                                                                1 (100%)                                           
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    7                                                              
                                                                                                                                   
NTP Experiment-Test: 05203-08         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                           O-NITROTOLUENE                                      Date: 11/16/00    
Route: DOSED FEED                                                                                                 Time: 09:23:03    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS MALE                     0 PPM        625 PPM      1250 PPM     2000 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
   Pancreas                                           (60)         (60)         (60)         (60)                                   
      Atrophy                                         11 (18%)     14 (23%)      7 (12%)      4 (7%)                                
      Acinus, Hyperplasia, Focal                       1 (2%)       2 (3%)       3 (5%)       4 (7%)                                
   Salivary Glands                                    (60)         (60)         (59)         (60)                                   
      Atrophy                                                       2 (3%)      18 (31%)     43 (72%)                               
   Stomach, Forestomach                               (59)         (60)         (60)         (60)                                   
      Edema                                            4 (7%)       2 (3%)                    1 (2%)                                
      Ulcer                                            2 (3%)       2 (3%)       1 (2%)       1 (2%)                                
      Epithelium, Hyperplasia                          6 (10%)      2 (3%)       1 (2%)       2 (3%)                                
   Stomach, Glandular                                 (59)         (60)         (60)         (60)                                   
      Edema                                                                                   1 (2%)                                
      Erosion                                          4 (7%)       2 (3%)       7 (12%)      7 (12%)                               
      Infiltration Cellular, Lymphoid                  1 (2%)                                                                       
      Ulcer                                            1 (2%)       2 (3%)                    3 (5%)                                
   Tongue                                             (1)                       (1)                                                 
      Epithelium, Hyperplasia                          1 (100%)                                                                     
   Tooth                                                                                     (1)                                    
      Malformation                                                                            1 (100%)                              
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (60)         (60)         (60)         (60)                                   
      Cardiomyopathy                                  40 (67%)     43 (72%)     43 (72%)     37 (62%)                               
      Thrombosis                                       1 (2%)       1 (2%)       1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (60)         (60)         (60)         (60)                                   
      Accessory Adrenal Cortical Nodule               13 (22%)     12 (20%)     13 (22%)     10 (17%)                               
      Degeneration, Fatty                             16 (27%)     10 (17%)     11 (18%)      4 (7%)                                
      Hyperplasia, Diffuse                                                       1 (2%)       3 (5%)                                
      Hyperplasia, Focal                               6 (10%)      2 (3%)       6 (10%)      3 (5%)                                
      Hypertrophy, Focal                               3 (5%)       2 (3%)       2 (3%)                                             
   Adrenal Medulla                                    (60)         (60)         (60)         (59)                                   
      Hyperplasia                                      7 (12%)      4 (7%)       2 (3%)                                             
   Islets, Pancreatic                                 (60)         (60)         (60)         (60)                                   
      Hyperplasia                                      2 (3%)                                 2 (3%)                                
      Pigmentation                                     1 (2%)                                 2 (3%)                                
   Parathyroid Gland                                  (58)         (55)         (59)         (58)                                   
      Hyperplasia                                                   1 (2%)                                                          
   Pituitary Gland                                    (59)         (60)         (58)         (59)                                   
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    8                                                              
                                                                                                                                   
NTP Experiment-Test: 05203-08         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                           O-NITROTOLUENE                                      Date: 11/16/00    
Route: DOSED FEED                                                                                                 Time: 09:23:03    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS MALE                     0 PPM        625 PPM      1250 PPM     2000 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ENDOCRINE SYSTEM - CONT                                                                                                             
      Pars Distalis, Angiectasis                       3 (5%)                    7 (12%)      2 (3%)                                
      Pars Distalis, Cyst                              2 (3%)       6 (10%)      3 (5%)       4 (7%)                                
      Pars Distalis, Cytoplasmic Alteration            1 (2%)                    1 (2%)       4 (7%)                                
      Pars Distalis, Hyperplasia, Focal               10 (17%)     13 (22%)     13 (22%)     10 (17%)                               
      Pars Intermedia, Cyst                                         1 (2%)       1 (2%)                                             
   Thyroid Gland                                      (59)         (60)         (60)         (60)                                   
      Ultimobranchial Cyst                                          1 (2%)       2 (3%)       3 (5%)                                
      C-Cell, Hyperplasia                             10 (17%)     11 (18%)      9 (15%)      7 (12%)                               
      Follicle, Cyst                                   3 (5%)       2 (3%)                                                          
      Follicular Cell, Hyperplasia                     1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   Peritoneum                                         (3)          (21)         (33)         (46)                                   
      Mesothelium, Hyperplasia                         1 (33%)      1 (5%)       4 (12%)      2 (4%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Epididymis                                         (60)         (60)         (59)         (60)                                   
      Atypia Cellular                                 39 (65%)     32 (53%)     27 (46%)     21 (35%)                               
      Fibrosis                                                      2 (3%)                                                          
      Inflammation, Chronic                                         1 (2%)                                                          
   Preputial Gland                                    (60)         (59)         (58)         (56)                                   
      Atrophy                                          7 (12%)      9 (15%)     35 (60%)     41 (73%)                               
      Cyst                                             1 (2%)       4 (7%)       1 (2%)                                             
      Hyperplasia                                                   1 (2%)                                                          
      Inflammation, Chronic                           40 (67%)     43 (73%)     36 (62%)     27 (48%)                               
   Prostate                                           (60)         (59)         (60)         (60)                                   
      Inflammation, Chronic                           24 (40%)     14 (24%)     18 (30%)      9 (15%)                               
      Ventral, Hyperplasia                            18 (30%)      3 (5%)       9 (15%)      1 (2%)                                
   Testes                                             (60)         (60)         (60)         (60)                                   
      Angiectasis                                                                             2 (3%)                                
      Germinal Epithelium, Atrophy                    13 (22%)     21 (35%)     12 (20%)     19 (32%)                               
      Interstitial Cell, Hyperplasia                  10 (17%)     14 (23%)     13 (22%)     31 (52%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (60)         (60)         (60)         (60)                                   
      Hyperplasia                                      2 (3%)      25 (42%)     43 (72%)     45 (75%)                               
   Lymph Node                                         (16)         (14)         (4)          (9)                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    9                                                              
                                                                                                                                   
NTP Experiment-Test: 05203-08         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                           O-NITROTOLUENE                                      Date: 11/16/00    
Route: DOSED FEED                                                                                                 Time: 09:23:03    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS MALE                     0 PPM        625 PPM      1250 PPM     2000 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
      Iliac, Hyperplasia, Lymphoid                                                            1 (11%)                               
      Mediastinal, Atrophy                                                                    1 (11%)                               
      Mediastinal, Hemorrhage                          2 (13%)      3 (21%)      1 (25%)      2 (22%)                               
      Mediastinal, Pigmentation                        6 (38%)      9 (64%)      3 (75%)      8 (89%)                               
      Pancreatic, Pigmentation                         1 (6%)       1 (7%)                                                          
      Renal, Ectasia                                                             1 (25%)                                            
      Renal, Pigmentation                              1 (6%)                    1 (25%)                                            
   Lymph Node, Mandibular                             (58)         (59)         (58)         (59)                                   
      Atrophy                                                                                 1 (2%)                                
      Ectasia                                          2 (3%)                                                                       
      Hemorrhage                                       2 (3%)       2 (3%)       1 (2%)       1 (2%)                                
      Hyperplasia, Lymphoid                            3 (5%)       4 (7%)       3 (5%)       2 (3%)                                
      Pigmentation                                     9 (16%)      2 (3%)       6 (10%)     12 (20%)                               
   Lymph Node, Mesenteric                             (60)         (60)         (59)         (58)                                   
      Atrophy                                          1 (2%)                    2 (3%)       1 (2%)                                
      Hemorrhage                                       2 (3%)       6 (10%)      3 (5%)       2 (3%)                                
      Pigmentation                                     3 (5%)       3 (5%)                                                          
   Spleen                                             (60)         (60)         (60)         (60)                                   
      Fibrosis                                         6 (10%)      6 (10%)      9 (15%)      7 (12%)                               
      Hematopoietic Cell Proliferation                 7 (12%)     33 (55%)     38 (63%)     47 (78%)                               
      Hemorrhage                                                    2 (3%)                                                          
      Pigmentation                                     9 (15%)      8 (13%)     13 (22%)     16 (27%)                               
      Capsule, Fibrosis                                                                       1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (57)         (47)         (46)         (43)                                   
      Dilatation                                       3 (5%)      10 (21%)      1 (2%)       1 (2%)                                
      Galactocele                                      2 (4%)                                                                       
      Hyperplasia                                      6 (11%)      2 (4%)       2 (4%)       2 (5%)                                
   Skin                                               (60)         (60)         (60)         (60)                                   
      Cyst                                                          1 (2%)                                                          
      Inflammation, Chronic                            1 (2%)                    1 (2%)                                             
      Subcutaneous Tissue, Edema                                                 1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (60)         (60)         (60)         (60)                                   
      Cranium, Osteopetrosis                                        1 (2%)                    2 (3%)                                
   Skeletal Muscle                                    (1)          (5)          (3)                                                 
      Atrophy                                          1 (100%)                                                                     
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page   10                                                              
                                                                                                                                   
NTP Experiment-Test: 05203-08         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                           O-NITROTOLUENE                                      Date: 11/16/00    
Route: DOSED FEED                                                                                                 Time: 09:23:03    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS MALE                     0 PPM        625 PPM      1250 PPM     2000 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
MUSCULOSKELETAL SYSTEM - CONT                                                                                                       
      Hemorrhage                                                    1 (20%)                                                         
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (60)         (60)         (60)         (60)                                   
      Compression                                      6 (10%)      3 (5%)       2 (3%)       1 (2%)                                
      Developmental Malformation                                                              1 (2%)                                
      Gliosis                                                       1 (2%)                                                          
      Hemorrhage                                       1 (2%)                                                                       
      Hydrocephalus                                    3 (5%)       1 (2%)       1 (2%)       2 (3%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (60)         (60)         (60)         (60)                                   
      Congestion                                                    1 (2%)                                                          
      Hemorrhage                                       3 (5%)                    1 (2%)                                             
      Infiltration Cellular, Histiocyte               25 (42%)     42 (70%)     40 (67%)     22 (37%)                               
      Metaplasia, Osseous                              1 (2%)       1 (2%)       1 (2%)                                             
      Alveolar Epithelium, Hyperplasia                 2 (3%)       8 (13%)      3 (5%)       7 (12%)                               
   Nose                                               (60)         (60)         (60)         (60)                                   
      Foreign Body                                     9 (15%)     13 (22%)     10 (17%)     11 (18%)                               
      Inflammation, Chronic                            9 (15%)      9 (15%)      8 (13%)      9 (15%)                               
      Inflammation, Suppurative                                                  2 (3%)                                             
      Respiratory Epithelium, Hyperplasia              6 (10%)      5 (8%)       7 (12%)      8 (13%)                               
      Respiratory Epithelium, Metaplasia, Squamous     2 (3%)       1 (2%)       1 (2%)       1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (2)          (1)          (2)          (1)                                    
      Atrophy                                          1 (50%)                                                                      
      Cataract                                                      1 (100%)     1 (50%)      1 (100%)                              
      Inflammation, Chronic                            1 (50%)                                                                      
      Retina, Degeneration                             1 (50%)      1 (100%)     1 (50%)      1 (100%)                              
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (60)         (60)         (60)         (60)                                   
      Cyst                                                          1 (2%)       3 (5%)       2 (3%)                                
      Infarct                                                                                 1 (2%)                                
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page   11                                                              
                                                                                                                                   
NTP Experiment-Test: 05203-08         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                           O-NITROTOLUENE                                      Date: 11/16/00    
Route: DOSED FEED                                                                                                 Time: 09:23:03    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         FISCHER 344 RATS MALE                     0 PPM        625 PPM      1250 PPM     2000 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
URINARY SYSTEM - CONT                                                                                                               
      Inflammation, Chronic                                         1 (2%)                                                          
      Mineralization                                                             1 (2%)                                             
      Nephropathy                                     56 (93%)     59 (98%)     56 (93%)     56 (93%)                               
      Renal Tubule, Degeneration, Hyaline              3 (5%)       3 (5%)                    1 (2%)                                
      Renal Tubule, Dilatation                         1 (2%)       3 (5%)                    2 (3%)                                
      Renal Tubule, Necrosis                                        1 (2%)       1 (2%)                                             
      Renal Tubule, Pigmentation                       5 (8%)      12 (20%)     14 (23%)      9 (15%)                               
      Transitional Epithelium, Hyperplasia             1 (2%)                    1 (2%)                                             
   Urinary Bladder                                    (60)         (60)         (60)         (59)                                   
      Fibrosis                                                                   1 (2%)       2 (3%)                                
      Inflammation, Chronic                                                      2 (3%)                                             
      Transitional Epithelium, Hyperplasia                          2 (3%)       2 (3%)       3 (5%)                                
      Transitional Epithelium, Inflammation,                                                                                        
          Chronic                                                                             1 (2%)                                
                                                                                                                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                             Page   12                                                              
                                                                                                                                   
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------